slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
24,3 CAD | +1,17% | +3,14% | +7,19% |
17/05 | ABBVIE INC. : Cantor Fitzgerald handhaaft koopadvies | ZM |
15/05 | Transcript : AbbVie Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM |
Vakgebied
De netto-omzet is als volgt geografisch verdeeld: Verenigde Staten (77,1%), Duitsland (2,3%), Canada (2%), Japan (1,9%), China (1,7%), Frankrijk (1,4%), Spanje ( 0,9%), Italië (0,9%), Australië (0,9%), Brazilië (0,8%), Verenigd Koninkrijk (0,8%) en overige (9,3%).
Aantal werknemers: 50 000
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Immunology
48,1
%
| 28 924 | 49,8 % | 26 136 | 48,1 % | -9,64% |
Neuroscience
14,2
%
| 6 528 | 11,2 % | 7 717 | 14,2 % | +18,21% |
Other
12,6
%
| 7 991 | 13,8 % | 6 841 | 12,6 % | -14,39% |
Oncology
10,9
%
| 6 577 | 11,3 % | 5 915 | 10,9 % | -10,07% |
Aesthetics
9,7
%
| 5 333 | 9,2 % | 5 294 | 9,7 % | -0,73% |
Eye Care
4,4
%
| 2 701 | 4,7 % | 2 415 | 4,4 % | -10,59% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
77,1
%
| 45 713 | 78,7 % | 41 883 | 77,1 % | -8,38% |
All Other Countries
9,3
%
| 4 837 | 8,3 % | 5 042 | 9,3 % | +4,24% |
Germany
2,3
%
| 1 340 | 2,3 % | 1 266 | 2,3 % | -5,52% |
Canada
2,0
%
| 1 159 | 2,0 % | 1 076 | 2,0 % | -7,16% |
Japan
1,9
%
| 956 | 1,6 % | 1 008 | 1,9 % | +5,44% |
China
1,7
%
| 912 | 1,6 % | 950 | 1,7 % | +4,17% |
France
1,4
%
| 787 | 1,4 % | 780 | 1,4 % | -0,89% |
Spain
0,9
%
| 506 | 0,9 % | 501 | 0,9 % | -0,99% |
Italy
0,9
%
| 444 | 0,8 % | 484 | 0,9 % | +9,01% |
Australia
0,9
%
| 508 | 0,9 % | 472 | 0,9 % | -7,09% |
Brazil
0,8
%
| 430 | 0,7 % | 439 | 0,8 % | +2,09% |
United Kingdom
0,8
%
| 462 | 0,8 % | 417 | 0,8 % | -9,74% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 01-01-13 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 01-01-13 |
Robert Michael
PSD | President | 53 | 01-01-12 |
Thomas Hudson
CTO | Chief Tech/Sci/R&D Officer | 62 | 01-01-16 |
Chief Operating Officer | 60 | 01-01-13 | |
Todd D. Bosse
IRC | Investor Relations Contact | - | 01-12-21 |
Roopal Thakkar
PRN | Corporate Officer/Principal | - | 01-01-03 |
Kevin Buckbee
AUD | Comptroller/Controller/Auditor | 58 | 01-03-23 |
Perry Siatis
LAW | General Counsel | - | 01-10-22 |
Carrie Strom
PRN | Corporate Officer/Principal | - | 08-05-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 01-01-13 |
Edward Rapp
BRD | Director/Board Member | 66 | 01-01-13 |
Director/Board Member | 70 | 01-01-13 | |
Glenn Tilton
BRD | Director/Board Member | 75 | 01-01-13 |
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 01-01-13 |
Thomas Freyman
BRD | Director/Board Member | 69 | 08-05-20 |
William Burnside
BRD | Director/Board Member | 72 | 01-01-13 |
Brett Hart
BRD | Director/Board Member | 54 | 01-01-16 |
Robert Alpern
BRD | Director/Board Member | 73 | 01-01-13 |
Robert Michael
PSD | President | 53 | 01-01-12 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 830 102 293 | 1 763 861 636 ( 96,38 %) | 64 234 512 ( 3,510 %) | 96,38 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
2 749 855 | 6.62% | 4 509 762 $ | |
IM CANNABIS CORP. 5.65% | 757 172 | 5.65% | 429 317 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
AbbVie Biopharmaceuticals GmbH Taiwan Branch
| |
AbbVie AG
| |
AbbVie International SARL
| |
AbbVie Bahamas Ltd.
| |
AbbVie Pte Ltd.
AbbVie Pte Ltd. Pharmaceuticals: MajorHealth Technology AbbVie Pte Ltd. operates as a research-based pharmaceutical company. The company was founded in January 1, 2013 and is headquartered in Singapore, Singapore. |
Pharmaceuticals: Major
|
AbbVie A/S (Denmark)
AbbVie A/S (Denmark) Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie A/S is a Danish biopharmaceutical company that develops and manufactures medicines. The company is based in Copenhagen, Denmark. |
Pharmaceuticals: Major
|
AbbVie Biopharmaceuticals GmbH
| |
AbbVie sro
AbbVie sro Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie sro is a Czech company that develops and manufactures pharmaceutical products. The company is located in Czechia. |
Pharmaceuticals: Major
|
AbbVie Operations Singapore Pte Ltd.
AbbVie Operations Singapore Pte Ltd. BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Operations Singapore Pte Ltd. is a Singaporean company that develops therapies and clinical medicines. The company is located in Singapore. |
Biotechnology
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,01% | 705 mld. | |
+32,82% | 583 mld. | |
-3,61% | 364 mld. | |
+20,18% | 332 mld. | |
+16,64% | 238 mld. | |
-4,13% | 210 mld. | |
+10,63% | 209 mld. | |
+8,92% | 169 mld. | |
-1,38% | 162 mld. |
- Beurs
- Aandelen
- Koers ABBV
- Koers ABBV
- Onderneming AbbVie Inc.